urosphere
News & events
Urosphere unveils its new web site
UROsphere is pleased to present its new web site that has been redesigned to offer enhanced functionality to better fit with our clients’ needs: Quick access to our assays, models and expertise A restricted area dedicated to our clients Personalized filter by disease area listing pertinent publications Subscribe to our RSS feed to receive our news updates Feel free to contact us with any questions or comments, we will be happy to assist you.
Urosphere will attend ICS annual meeting and present several scientific communications. (Rotterdam, Netherlands, August 20-24, 2007)
View the posters presented. If you wish to meet UROsphere's senior managers during ICS meeting, please contact us.
UROsphere to present scientific results at ICS annual meeting (Egypt, 20-24 October 2008)
The following poster will be presented during the meeting: Palea S, Deba A, Lluel P. Activation of ß3-adrenoceptors inhibits neurogenic contraction in mouseisolated urinary bladder. UROsphere's top management will be present during the congress. If you wish to meet them, please contact us
UROsphere to present scientific results at ICS annual meeting (San Francisco, 29th September – 3rd October 2009)
The following posters will be presented: - Lluel P, Guerard M, Palea S, Julia-Guilloteau V. Duloxetine counteracts bladder overactivity induced by intravesical acetic acid in anesthetized female guinea-pigs through activation of 5-HT receptors. - Lluel P, Chene G, Dubourdeau M, Vergnolle N, Palea S, Coelho AM. Increase in arachidonic acid metabolites in the urine of female rats with cyclophosphamide-induced cystitis. UROsphere's top managers will be present during the...
UROsphere to present scientific results at AUA annual meeting (USA, 25-30 April 2009)
Following posters will be presented in different sessions: - Deba A, Lluel P, Palea S. Functional evidence of β3-adrenoceptors (β3-AR) in female mouse isolated urinary bladder. - Deba A, Palea S, Parini A, Lluel P. Differential gene expression in bladder hypertrophy following bladder outlet obstruction in mouse. - Lluel P, Guilloteau V, Guerard M, Pietra C, Lovati E, Palea S. Netupitant, a new selective NK1 receptor antagonist, reverses acetic acid-induced bladder overactivity in anesthetized...
UROsphere to present scientific results at EAU annual meeting (Stockholm, Sweden, 17-21 March , 2009)
UROsphere will take part in the European Association of Urology's Annual Meeting and present scientific results on BPH research: Gilles N, Lluel P, Rekik M, Guerard M, Palea S. AdTx1, a new peptidic α1-adrenoceptor antagonist with high affinity and selectivity for human α1A-adrenoceptor subtype: pharmacological characterization. The company's top managers will also present the company's expertise to members of the Medicon Valley biotech cluster (in Sweden and Denmark) in March 2009. To read...
UROsphere will be present at BIO EUROPE (Germany, 17-19th november 2008)
To meet UROsphere top management, please contact usFor more information on this event click here
UROsphere will be participating in Bio Japan 2008 (15-17 October 2008)
For more information on this event, click here .
UROsphere will be present at the CRO-Biotech BIOConnexion (Paris, 6th October 2008)
To meet us during this event, please contact usFor more information on this event organized by Info Veille Biotech, click here
UROsphere and Vectalys selected by the SISMIP for their research programme « Discovery of new targets for prostatic pathologies»
The 3SI program for Innovation in the Health Sector is a call for innovative projects reserved to SMEs located in Midi-Pyrenees Region. This program is also supported by the Regional Board of OSEO (France's national agency for industrial innovation), the Regional Board for Research and Technology (DRRT), the Cancer-Bio-Health cluster and Midi Pyrénées Innovation (MPI). UROsphere and Vectalys (a company specialized in viral vector production and cell transduction expertises for gene discovery...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
SSR240600, a selective neurokinin NK1 receptor antagonist, reduces micturition frequency in anesthetized female guinea-pigs and may be useful as a treatment of human OAB.
Lluel P et al. Aspet-Ray Fuller Symposium, Lower Urinary Tract Disorders, July 6-7, 2002.
